Real Tech Fund supports the development of medical devices originating in Japan and the commercialization of medical-related technologies
Invested in "Japan Medical Device Development Organization"

Euglena Investment Co., Ltd.

　Euglena Investment Co., Ltd. (Headquarters: Minato-ku, Tokyo, Representative: Akihiko Nagata) is a new investment destination for the venture capital fund "Real Tech Fund", such as development of medical equipment, commercialization support of medical-related technology, manufacturing and sales, etc. We are pleased to inform you that we have invested in the Japanese Organization for Medical Device Development (JOMDD).

　The market for the medical device industry is about 40 trillion yen worldwide, but in Japan, many overseas-made medical devices are used, and the medical device field has an annual trade deficit of more than 700 billion yen. .. This is because, despite the fact that Japan has excellent clinicians, research institutes / university hospitals with abundant achievements, and companies with high technological capabilities, the needs and seeds obtained from these three parties in the medical device field. The factor was the lack of human resources and functions to commercialize the related technologies that we own.
　Based on these circumstances, we have gathered human resources with abundant experience in the development and commercialization of medical-related technologies, including Mr. Takehiko Uchida (representative of JOMDD) who was a medical device examiner of the US Food and Drug Administration (FDA). , JOMDD is a company established with the aim of providing Japan's excellent medical technology to the world. JOMDD has partnered with the Japan Medical Association to develop and develop new medical devices and technologies based on the network of approximately 166,000 doctors belonging to the Japan Medical Association and the needs of doctors in the medical field. We are promoting the support for conversion.
　This time, the Real Tech Fund will provide funds by underwriting the shares issued by JOMDD through a third-party allotment, and while supporting the company's business development, it will provide its know-how regarding the development and commercialization of medical devices. We plan to utilize it to foster medical-related businesses promoted by the investment destinations of Real Tech Fund.
　The details are as follows.

Investing in Japan Medical Device Development Organization (JOMDD)

■ About Japan Medical Device Development Organization Co., Ltd. and support contents

■ About Real Tech Fund (HP: www.euglena-investment.jp)
　Our 100% subsidiary of Euglena Investment, SMBC Nikko Securities, Ribanesu "Limited Liability Company was founded three companies Euglena in venture capital funds that SMBC Nikko Ribanesu capital" to management and operation, the investment development of the real tech venture as the main purpose is. With a total of 17 participating companies and a fund size of 5.5 billion yen (as of January 2016), it is Japan's largest fund specializing in real tech. We are investing in and nurturing real tech ventures with the following operating companies that are investors.

Investors: Euglena Investment Co., Ltd., Revanes Co., Ltd., SMBC Nikko Securities Co., Ltd., Nippon Tobacco Industry Co., Ltd., Mitsui Real Estate Co., Ltd., Yoshinoya Holdings Co., Ltd., Rohto Pharmaceutical Co., Ltd., Kanetsu Co., Ltd., Dentsu Co., Ltd., Tokyo Century Lease Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Aizawa Securities Co., Ltd., Shimizu Construction Co., Ltd., Sumitomo Mitsui Banking Corporation, ANA Holdings Co., Ltd., THK Co., Ltd., Toyo Aluminum Co., Ltd. (17 companies in total)

​ ​

-Contact for inquiries from the press-
Euglena Co., Ltd. Public Relations and IR Division